Khairy: Malaysia, Merck sign agreement for Covid-19 drug ...

The Star Online - 07 Oct 2021
PUTRAJAYA: Malaysia has signed an agreement with Merck Sharp & Dohme (MSD) to procure antiviral medicine Molnupiravir for Covid-19 treatment.

Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial

The Lancet - 09 Sep 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial ...

Molnupiravir cuts risk for severe COVID-19 symptoms — and possibly long COVID

Healio - 18 Sep 2024
Molnupiravir cuts risk for severe COVID-19 symptoms — and possibly long COVID ...

Molnupiravir reduces long-term COVID-19 symptoms but shows limited impact on hospitalizations

News-Medical.Net - 11 Sep 2024
Molnupiravir reduces long-term COVID-19 symptoms but shows limited impact on hospitalizations ...

Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)

Business Wire - 18 Sep 2024
Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP) ...

Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief, studies find

University of Minnesota Twin Cities - 11 Nov 2024
Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief, studies find ...

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

Nature.com - 23 Feb 2024
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients ...

IDSA Guidelines on the Treatment and Management of Patients with COVID-19

IDSA - 12 Aug 2024
IDSA Guidelines on the Treatment and Management of Patients with COVID-19 ...

MedEthix leverages the synergy of strategic alliances to ease Molnupiravir access

Healthcare Asia - 27 Mar 2024
MedEthix leverages the synergy of strategic alliances to ease Molnupiravir access ...

Optimising reverse-phase chromatography for molnupiravir production

European Pharmaceutical Review - 03 Jul 2024
Optimising reverse-phase chromatography for molnupiravir production ...

Molnupiravir May Offer Modest 6-Month Benefits for High-Risk COVID Patients

Medpage Today - 11 Sep 2024
Molnupiravir May Offer Modest 6-Month Benefits for High-Risk COVID Patients ...

Efficacy of molnupiravir and interferon for the treatment of SARS-CoV-2 in golden Syrian hamster

Wiley Online Library - 29 Aug 2024
Efficacy of molnupiravir and interferon for the treatment of SARS-CoV-2 in golden Syrian hamster ...

COVID-19 Treatment Clinical Care for Outpatients

CDC - 12 Jul 2024
COVID-19 Treatment Clinical Care for Outpatients ...

Antiviral drug molnupiravir linked to new mutations in SARS-CoV-2

News-Medical.Net - 26 Sep 2024
Antiviral drug molnupiravir linked to new mutations in SARS-CoV-2 ...

RECOVERY trial finds no significant benefit of molnupiravir or Paxlovid for patients hospitalised with COVID-19

Nuffield Department of Population Health - 24 May 2024
RECOVERY trial finds no significant benefit of molnupiravir or Paxlovid for patients hospitalised with COVID-19 ...

Trial Shows Increased SARS-CoV-2 Mutations, Delayed Viral Clearance With Molnupiravir Treatment

IDSA - 29 Mar 2024
Trial Shows Increased SARS-CoV-2 Mutations, Delayed Viral Clearance With Molnupiravir Treatment ...

Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study | Scientific Reports

Nature.com - 09 Feb 2024
Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study | Scientific Reports ...

Evidence growing for COVID antivirals to cut poor outcomes, long COVID, experts say

University of Minnesota Twin Cities - 17 Sep 2024
Evidence growing for COVID antivirals to cut poor outcomes, long COVID, experts say ...

Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients

News-Medical.Net - 25 Mar 2024
Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients ...

Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID-19: A systematic review and meta-analysis

Wiley Online Library - 23 Apr 2024
Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID-19: A systematic review and meta-analysis ...

Molnupiravir